in childhood: parents 'experiences about the condition and their perspectives on child medication
DOI:
https://doi.org/10.21527/2176-7114.2022.46.13528Keywords:
PHDA, medicalização, progenitores, medicaçãoAbstract
ABSTRACT: Over the last few decades, there has been an increase in the prevalence of the diagnosis of attention deficit hyperactivity disorder, as well as of the concomitant therapy with psychostimulants. Research in this area reports the existence of children receiving pharmacological treatment for this disorder without meeting the respective diagnostic criteria, which points to a possible medicalization of the behaviors considered as socially deviant. This study intended to know parents’ perspectives on the children's problems and explore their role in signaling and seeking treatment. Particular emphasis was placed on their perspectives on the effects of medication, efficacy and long-term impact. With this purpose were interviewed 25 parents whose children had diagnosis of attention deficit hyperactivity disorder and were being medicated for this purpose. Participants were selected using the non-probability sampling methods of convenience and snowball. Most participants identified a set of cognitive, behavioral and emotional problems in children. The results emphasize the role of the school in signaling problems and point out that the pressure exerted by others, the concern with school performance and the lack of control over children's behavior are the main factors that motivate medical consultation. Regarding the intervention, there was a prioritization of pharmacological treatment by health professionals and a positive perspective from parents about the effectiveness of the medication, regardless of the side effects it produces.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Revista Contexto & Saúde
This work is licensed under a Creative Commons Attribution 4.0 International License.
By publishing in Revista Contexto & Saúde, authors agree to the following terms:
The works are licensed under the Creative Commons Atribuição 4.0 Internacional (CC BY 4.0) license, which allows:
Share — to copy and redistribute the material in any medium or format;
Adapt — to remix, transform, and build upon the material for any purpose, including commercial.
These permissions are irrevocable, provided that the following terms are respected:
Attribution — authors must be properly credited, with a link to the license and indication of any changes made.
No additional restrictions — no legal or technological measures may be applied that restrict the use permitted by the license.
Notes:
The license does not apply to elements in the public domain or covered by legal exceptions.
The license does not grant all rights necessary for specific uses (e.g., image rights, privacy, or moral rights).
The journal is not responsible for opinions expressed in the articles, which are the sole responsibility of the authors. The Editor, with the support of the Editorial Board, reserves the right to suggest or request modifications when necessary.
Only original scientific articles presenting research results of interest that have not been published or simultaneously submitted to another journal with the same objective will be accepted.
Mentions of trademarks or specific products are intended solely for identification purposes, without any promotional association by the authors or the journal.
License Agreement (for articles published from September 2025): Authors retain copyright over their article and grant Revista Contexto & Saúde the right of first publication.
